Mouse brains were removed from P0 mouse pups

Mouse brains were removed from P0 mouse pups. oxygen-glucose S3QEL 2 deprivation. However, primary astrocytes that were isolated from TG2 knock out mice were resistant to oxygen-glucose deprivationin situ. Both wild type and knock out neurons were protected against oxygen glucose deprivation when they were co-cultured with astrocytes from TG2 knockout mice. Therefore, the decreased stroke volumes observed in TG2 knock out mice after MCAL, can be correlated with the protective effects of TG2 knock out in astrocytes in response to oxygen glucose deprivationin situ. These findings suggest that neuron-astrocyte crosstalk plays a significant role in mediating ischemic cell death and that TG2 differentially impacts cell survival depending on cell context. Keywords:Transglutaminase 2, S3QEL 2 stroke, ischemia, hypoxia, middle cerebral artery ligation, cell death, neuron, astrocyte == Introduction == Stroke remains as a leading cause of death in the United States in part due to the lack of effective therapeutics for most patients (Cramer, 2011). The complexity of intracellular signaling mechanisms that are brought on in an ischemic event, as well as the variety of cell types that are affected in the brain, have made the search for effective treatments hEDTP a daunting task. However it is becoming increasingly obvious that subsequent to stroke the coordinated response of all the cells in the brain, including neurons, glia and vascular endothelial cells, plays a significant role in the final end result (Yenari and Lee, 2011). Therefore it is critically important to understand how each cell type responds to ischemic stress and in turn how this impacts the survival of the other cells in the affected area of the brain. Neuron-astrocyte interactions are especially important when it S3QEL 2 comes to neurodegenerative pathologies, as astrocytes have many functions that support the viability of neurons such as buffering the extracellular space, providing substrates to neurons and interchanging glutamate for glutamine (Verkhratsky and Toescu, 2006). Neurons and astrocytes respond differently to ischemic stress, in part due to differences in their cellular metabolism. Astrocytes are more dependent on glycolytic metabolism and they possess glycogen stores which makes them less susceptible to ischemia. In contrast, neurons are highly dependent on oxidative metabolism and thus are more sensitive to oxygen-glucose deprivation (Escartin et S3QEL 2 al., 2006). The support of neurons by astrocytes is very important in ischemic conditions. Deficits in astrocytes function can negatively impact stroke size and recovery. If the astrocytic functions such as extracellular buffering or glutamate uptake are compromised, infarct size might increase due to an increase loss of neurons (Rossi et al., 2007). Additionally, astrocytes express neuroprotective factors such as erythropoietin (EPO) (Diaz et al., 2005;Liu et al., 2006), vascular endothelial growth factor (VEGF) (Rosenstein and Krum, 2004) and adenosine (Hamilton and Attwell, 2010;Schubert et al., 1997) that facilitate neuronal survival in ischemia. On the other hand, astrocytes also release neurotoxic factors such as nitric oxide (NO) which can potentiate neuronal cell death (Hu et al., 1997;Saha and Pahan, 2006). Therefore, the role of astrocytes in ischemic neuronal death is a crucial factor in regulating the size of an infarct. Transglutaminase 2 (TG2) belongs to a family of enzymes that catalyze Ca2+dependent transamidation reactions which can form isopeptide bonds between the -carboxamide group of a peptide bound glutamine residue and -amino group of a lysine residue (Griffin et al., 2002). TG2 can either facilitate or attenuate S3QEL 2 cell survival depending on the stressor, as well as the cell type (Gundemir and Johnson, 2009). In neurons, TG2 was found to be protective against ischemic cell death both in vitro.